Trial intelligence / Profile preview

Walking the Isobole of Drug Interaction

2013-002883-20Phase 4Active

Sponsor
University Medical Center Groningen
Start
Jul 2013
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of remifentanil and propofol, sponsored by University Medical Center Groningen. Started Jul 2013; status: active.

02

Drugs

remifentanilpropofol

Beyond the preview

Go deeper on 2013-002883-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-002883-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call